PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 50.00K | 50.00K | 50.00K | 75.00K | 75.00K |
| Gross Profit | -50.00K | -50.00K | -50.00K | -75.00K | -75.00K |
| SG&A Expenses | 2.36M | 3.37M | 3.90M | 4.95M | 6.00M |
| Depreciation & Amortization | 114.00K | 152.00K | 152.00K | 114.00K | 76.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.67M | 3.86M | 4.49M | 5.55M | 6.84M |
| Operating Income | -2.67M | -3.86M | -4.49M | -5.55M | -6.84M |
| Income Before Tax | -2.86M | -4.11M | -4.89M | -6.24M | -7.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.86 | -4.11 | -4.89 | -6.24 | -7.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.86M | -4.11M | -4.89M | -6.24M | -7.63M |
| EBIT | -2.67M | -3.86M | -4.49M | -5.55M | -6.84M |
| EBITDA | -2.54M | -3.71M | -4.34M | -3.47M | -2.65M |
| EPS Basic | -0.02 | -0.04 | -0.04 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.02 | -0.04 | -0.04 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 479.03M | 462.74M | 447.26M | 449.12M | 451.13M |
| Average Diluted Shares Outstanding | 479.03M | 462.74M | 447.26M | 449.12M | 451.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |